Q&A: Sanofi's new research chief on AI, R&D failure rates and dealmaking

EarningsNeutral

AI Analysis

Summary

Endpoints News interviewed Paulo Fontoura, who became Sanofi's global head of R&D in September after 16 years at Roche and a stint at AI startup Xaira Therapeutics. The Q&A, published ahead of Sanofi's Oct. 30 earnings, covers AI, R&D failure rates and dealmaking.

Importance:4/10

Sentiment:

0.10

SanofiR&D leadershipinterviewAI drug discoverydealmakingmanagement change

Related Companies

$SNY $RHHBY

Read the original article

Published by Endpoints News on October 16, 2026 4:02 PM

Read Original